Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

gerry wright

Promising new antimalarial compound discovered in McMaster-Hamburg collaboration

, 3 November 2021/in E-News /by panglobal

A study out of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University has resulted in the discovery of a promising new antimalarial compound.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/gerry_wright-scaled.jpg 1707 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 10:13:232021-11-03 10:13:23Promising new antimalarial compound discovered in McMaster-Hamburg collaboration
research europe

3 research infrastructures form new biomedical alliance EU-AMRI

, 3 November 2021/in E-News /by panglobal

BBMRI, EATRIS and ECRIN, the medical European research infrastructures, supported by the European Strategy Forum on Research Infrastructures (ESFRI), have joined forces by forming the European Alliance of Medical Research Infrastructures (EU-AMRI). EU-AMRI aims to facilitate the effective and efficient use of scientific services, expertise and tools by academia and industry for the seamless translation […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/research_europe.jpg 1024 1200 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 10:10:472021-11-03 10:10:473 research infrastructures form new biomedical alliance EU-AMRI
cell nanofibres

New technology allows molecules to enter cells safely

, 3 November 2021/in E-News /by panglobal

Professor Braeckmans from Ghent University focused the last ten years on a method for safe engineering of therapeutic cells with photothermal nanofibers. The study published in Nature Nanotechnology gives insight in how these biocompatible photothermal nanofibers were developed, and how, upon laser irradiation, cells that come in contact with those nanofibers become permeabilized and can […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/cell_nanofibres.jpg 623 481 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 10:07:232021-11-03 10:07:23New technology allows molecules to enter cells safely

Exploiting AKIRIN2 to develop selective proteasome-inhibiting drugs

, 3 November 2021/in E-News /by panglobal

Inhibitors that block the activity of the proteasome are already applied to treat various types of cancer. However, existing drugs affect proteasomes in all the cells of our body, which can lead to unwanted side-effects in healthy cells.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 10:01:592021-11-03 10:01:59Exploiting AKIRIN2 to develop selective proteasome-inhibiting drugs

AKIRIN2: two fingers pulling the proteasome into the nucleus

, 3 November 2021/in E-News /by panglobal

The scientists found that AKIRIN2 was consistently associated with the proteasome and not only required for the regulation of MYC, but of many more short-lived proteins. To their surprise, they found that AKIRIN2 only affected nuclear proteins, which accumulated freely in its absence. Thus, they hypothesised that AKIRIN2 might help the proteasome to enter the […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 09:56:282021-11-03 09:57:36AKIRIN2: two fingers pulling the proteasome into the nucleus
akirin

How cells keep their nucleus clean: a fundamental discovery

, 3 November 2021/in E-News /by panglobal

Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna have developed a CRISPR-Cas9 screening assay that allows to systematically pinpoint regulators of any gene of interest, including cancer-related genes. Using this approach, they discovered how cells transport their clean-up machinery, the proteasome, into the nucleus to maintain protein balance and get rid of […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/akirin-scaled.jpg 1707 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 09:53:262021-11-03 09:53:26How cells keep their nucleus clean: a fundamental discovery
CN Bio

CN Bio expands service offering to support oncology drug discovery

, 3 November 2021/in E-News /by panglobal

CN Bio, a leading organ-on-a-chip company that designs and manufactures single- and multi-organ microphysiological systems (MPS), has launched its Oncology Service in response to the global need to improve cancer drug discovery approval rates.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/CN-Bio.jpg 484 1124 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 08:17:282021-11-03 08:17:28CN Bio expands service offering to support oncology drug discovery
evonetix dna

Evonetix granted patent for DNA data storage and retrieval method

, 3 November 2021/in E-News /by panglobal

Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, has been granted patent GB 2576304 for its novel method for DNA data storage and retrieval.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/evonetix_dna.jpg 1073 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 08:15:272021-11-03 08:15:27Evonetix granted patent for DNA data storage and retrieval method
Fujifilm Tilburg

FUJIFILM Irvine Scientific’s European manufacturing facility to boost production of cell culture media products

, 3 November 2021/in E-News /by panglobal

FUJIFILM Irvine Scientific, has completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility and equipment in anticipation of full operations starting in late 2021. The new facility will join manufacturing locations in the U.S. and Japan to increase […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/Fujifilm-Tilburg.jpg 632 950 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 08:11:302021-11-03 08:11:30FUJIFILM Irvine Scientific’s European manufacturing facility to boost production of cell culture media products
selux NGP

Selux Diagnostics awarded $2.8 million NIH grant for commercialization of its NGP platform

, 3 November 2021/in E-News /by panglobal

Selux Diagnostics, which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, has received a $2.8 million award from the U.S. National Institutes of Health (NIH) to help the company commercialize its NextGen ‘Phenotyping’ (NGP) platform for rapid antimicrobial susceptibility testing (AST). Having recently completed its first clinical […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/selux_NGP.jpg 814 1218 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2021-11-03 07:58:232021-11-03 07:58:23Selux Diagnostics awarded $2.8 million NIH grant for commercialization of its NGP platform
Page 61 of 228«‹5960616263›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription